Home › Funds › Millennium Management › NMRA
Millennium Management position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)509.21K sh
Reported value held$865.66K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 274.75K | $3.88M | New |
| Q1 2024 | 136.53K | $1.88M | New |
| Q4 2024 | 882.43K | $9.35M | New |
| Q1 2025 | 718.33K | $718.33K | Reduce |
| Q2 2025 | 1.23M | $902.98K | Add |
| Q3 2025 | 2.01M | $3.66M | Add |
| Q4 2025 | 3.62M | $6.47M | Add |
| Q1 2026 | 2.75M | $5.37M | Reduce |
| Q2 2026 | 509.21K | $865.66K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Citadel Advisors 1.07M sh · $1.82M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026